Skip to main content
. 2021 Dec 27;13(3):394–403. doi: 10.1111/1759-7714.14271

FIGURE 4.

FIGURE 4

Subgroup analysis of OS between patients in the IO+C and C groups. (a) Male subgroup. (b) Female subgroup. (c) Age ≤ 65 subgroup. (d) Bone metastasis subgroup. (e) Adrenal metastasis subgroup. (f) EGFR exon19 del mutation subgroup. (g) Third‐line treatment subgroup